A Novel Echocardiography-Guided Strategy for Percutateous Closure of Atrial Septal Defect Assisted by PannaWire
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 666 participants.
Also called NCT07054541
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 666 participants
- Registry
-
NCT07054541
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07054541. Randomized; single masking; primary purpose treatment. Start 2026-03-14 (anticipated); primary completion 2027-10-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Novel Echocardiography-Guided Strategy for Percutateous Closure of Atrial Septal Defect Assisted by PannaWire
- Acronym
- PANNA-ASD
- Condition
- Atrial Septal Defect (ASD)
- Intervention (Procedure)
- Ultrasound-guided intervention with assistance of specialized instruments
- Intervention (Procedure)
- fluoroscopy-guided intervention
- Lead sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital
Record details
- Record id
cardio:ct-nct07054541- Content hash
101fe770fa2fa786ae4c1269e112caa1a7a26355193feb66c8c163361adc830a